In Vitro Activities of Terbinafine against Aspergillus Species in Comparison with Those of Itraconazole and Amphotericin B

AUTOR(ES)

Moore, Caroline B.

FONTE

American Society for Microbiology

RESUMO

Compared with the in vitro activities of itraconazole (geometric mean MIC [GM], 0.56 μg/ml) and amphotericin B (GM, 0.66 μg/ml), the in vitro activity of terbinafine was inferior against Aspergillus fumigatus (GM, 19.03 μg/ml) (P < 0.05) and superior against A. flavus (GM, 0.10 μg/ml), A. terreus (GM, 0.16 μg/ml), and A. niger (GM, 0.19 μg/ml). Clinical correlation is required, as trailing endpoints are problematic.

Documentos Relacionados

• In vitro activity of SCH-56592 and comparison with activities of amphotericin B and itraconazole against Aspergillus spp.
• In Vitro Activity of the New Triazole BMS-207147 against Aspergillus Species in Comparison with Itraconazole and Amphotericin B
• In Vitro Comparison of Activities of Terbinafine and Itraconazole against Paracoccidioides brasiliensis
• Comparison of In Vitro Activity of Liposomal Nystatin against Aspergillus Species with Those of Nystatin, Amphotericin B (AB) Deoxycholate, AB Colloidal Dispersion, Liposomal AB, AB Lipid Complex, and Itraconazole
• Effect of pH on the In Vitro Activities of Amphotericin B, Itraconazole, and Flucytosine against Aspergillus Isolates